Search PubMed⌕ Search

Biomedical subjects

J Botey

Publications and source records attributed to J Botey.

41 records · Page 3Linked to original sources

Study of the sensitization to storage mites in a pediatric population in Barcelona.

We performed the following study in order to determine the prevalence and characteristics of sensitization to storage mites in children mostly from the city of Barcelona. All children over 3 years of age attending our unit for the first time due to respiratory problems were given cutaneous tests using the prick test for the house dust mites Dermatophagoides pteronyssinus and D. farinae, and the storage mites Acarus siro, Lepidoglyphus destructor and Tyrophagus putrescentiae. We carried out a RAST and conjunctival test when it was considered appropriate. Of a total of 356 children studied, 39 showed cutaneous sensitization to storage mites, which represented 11% of the population studied, and 20% of the total sensitized to mites. However, only 3 of these children were only sensitized to storage mites, the remaining 36 (92%) also showing sensitization to house dust mites. Of the storage mites studied, L. destructor was the most significant. A history of immunotherapy to mites was associated with a greater percentage of positive cutaneous tests to storage mites, although this was not the case with the RAST test.

Animals↗

[Perennial rhinitis: antihistaminic and anti-inflammatory treatment].

The use of various medications in chronic rhinitis in children is discussed. Evastin has been shown to eliminate histamine papules in 93% of cases and those caused by D. pteronyssinus in 68% of cases. After 10 days of treatment, conjunctival response decreased or disappeared in 80% of cases and nasal response decreased in 69%. Clinically, evastin was effective in 14 of 22 children and produced moderate effects in 2 and no effect in 6. There were no dropouts because of problems of tolerance. In a preliminary study of intranasal azelastin in 21 children with chronic allergic rhinitis, clinical improvement was significant. Various multicenter trials are reported, focusing on those using fluid budesonide. Both medications were effective in reducing symptoms and the antihistamine effect usually was earlier. There were no differences between medications as evaluated by nasal challenge or tolerance. Finally, budesonide was used in 13 patients for 4 months. Nasal obstruction and secretion improved, and rhinomanometry results improved significantly.

Adolescent↗

[Epidemiology and chronology of allergic diseases and their risk factors].

An increase in allergic diseases in Western societies has been observed in all epidemiological studies. Various risk factors have been invoked to explain this increase, but the results are still inconclusive. We examined the type of patients who visited a hospital pediatric allergology unit in terms of the type of pathology presented, environmental factors, and time from the onset of symptoms until referral for allergy study. We evaluated 200 children ranging in age from 1 month to 15 years who were distributed by pathology: 119 referrals for respiratory manifestations (asthma, rhinitis, coughing, ...), 46 for food-related pathology, and 35 for adverse reactions attributed to medications. Among the risk factors, 69% of the children had a family history, 63.5% were exposed to smoking, and all of the patients were from urban and urban-industrial areas. We found no relation between the type of pathology and birth month. The natural history of allergic disease showed the following sequence: food allergy--respiratory allergy--medication allergy. In every case there was an important delay in diagnosis. The patients who visited our department soonest were infants (for presumptive allergy to cow milk protein or suspected adverse reaction to medications). It is evident that in recent years we are seeing a major increase in allergic diseases, particularly in industrialized countries. From a clinical point of view, manifestations such as asthma, rhinitis, and atopic dermatitis are increasing, which all working groups attribute to an increase in the prevalence of allergy. Epidemiological studies of large population samples use non-standard methods, with different selection criteria, ethnic breakdown and geographic differences. This makes it difficult to compare available data. Therefore, we think that it would be advisable if epidemiological studies would attempt to follow a model, which would facilitate the comparison of studies. Our aim was to evaluate the type of patients who required allergy studies in relation to the pathologies that they present and the different diagnostic methods to determine the presence of false allergies or non-allergies, the delay until study, most frequent pathologies, and environment. We report the data obtained from a sample of 200 children who visited our department for the first time in the period of a natural year.

Adolescent↗

[From atopic dermatitis to asthma].

The prevalence of atopic dermatitis and other allergic diseases is increasing in industrialized countries. Today we know that atopy is conditioned genetically, but the development of the atopic phenotype requires environmental factors. It is believed that the genetic factors have not changed and that the increased prevalence is due to the increase in exposure to allergenic and non-specific environmental factors. The potential for sensitization is greater in the early years of life, so it is necessary to reduce harmful environmental exposure at these ages. Atopic clinical manifestations develop sequentially, in many cases beginning with atopic dermatitis in the early months of life. We know that children with atopic dermatitis present non-specific bronchial hyperreactivity (58 to 82%), which is a risk factor for the later development of asthma. The presence of specific bronchial hyperreactivity for mites in atopic dermatitis with mite sensitization also has been described, and it has been demonstrated that signs of eczema can develop or become exacerbated by airway exposure during bronchial challenge tests. The evolution from atopic dermatitis to asthma is a possibility that must be kept in mind. Patients should be followed-up and study of hyperreactivity and sensitization to allergens should be carried out in order to prevent the development of clinical symptoms. Prevention should include pneumoallergens, food allergens, and non-specific environmental risk factors, such as parental smoking (particularly mothers), pollution inside and outside the home, etc. Prevention is particularly important in children at risk of allergy, as determined by a family history among first-degree relatives, as well as the presence of atopic dermatitis, particularly of early onset, because these patient are most at risk of developing bronchial asthma in later years. At present, pharmacological prevention is being studied, without overlooking environmental prevention, in children at high risk of atopic disease for the purpose of preventing chronic inflammations that will condition their future as adults. In our daily clinical experience, atopic dermatitis is responsible for 8% of visits to a pediatric allergology unit. We emphasize that 62.5% of our patients with dermatitis are referred when they already have bronchial asthma, which represents an important delay in diagnosis with respect to the onset of symptoms.

Adult↗

Determination of total and specific IgE using UNICAP 100: comparative study with the CAP system.

The methods of serum determination of specific IgE to different allergens have showed lower diagnostic sensitivity than the alternative in vivo methods, the skin tests. The CAP system from Pharmacia, owing to its solid phase, has ameliorated this disadvantage, showing in various studies greater diagnostic sensitivity than the classic RAST, without affecting specificity. However, this system is still semi-automatic and requires daily calibration. UNICAP 100 is a completely automatic autoanalyser for total IgE, specific IgE and Eosinophil Cationic Protein, which combines the high sensitivity of the CAP system with complete automation and monthly calibration. The aim of the present study is to assess the practicality and reliability of UNICAP 100, when compared to the CAP System, for the determination of total IgE and specific IgE, as well as the sensitivity and diagnostic specificity; using as a reference skin tests in 150 paediatric patients. The coefficients of variation in the study of intraseries imprecision ranged between 2.1% and 3.6% for total IgE and between 2.2% and 5.1% for specific IgE, depending on the allergen and the level studied. The intraseries imprecision ranged between 3.3% and 7.7% for total IgE and between 5.2% and 8.9% for specific IgE. The coefficients of correlation of the study of interchangeability with the results of the CAP System varied between 0.985 and 0.998, all the allergens tested (9) being interchangeable. Finally, the diagnostic sensitivity varied between 70% and 95% and the specificity between 87% and 100%. In conclusion, UNICAP 100 showed results that were interchangeable with the CAP System, noticeably improving the benefits owing to its complete automation and its calibration system.

Allergens↗